Activation of Coagulation in C57BL/6 Mice Given Verotoxin 2 (VT2) and the Effect of Co-administration of LPS with VT2

This publication has 19 references indexed in Scilit:

• Low levels of tissue factor are compatible with development and hemostasis in mice.
  Journal of Clinical Investigation, 1998
• Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.
  Journal of Clinical Investigation, 1996
• Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome
  The Journal of Pediatrics, 1994
• Human Renal Microvascular Endothelial Cells as a Potential Target in the Development of the Hemolytic Uremic Syndrome as Related to Fibrinolysis Factor Expression, in Vitro
  Microvascular Research, 1994
• Role of Plasminogen-Activator Inhibitor Type 1 in the Pathogenesis and Outcome of the Hemolytic Uremic Syndrome
  New England Journal of Medicine, 1992
• The coagulation cascade: initiation, maintenance, and regulation
  Biochemistry, 1991
• Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 Infections
  The Journal of Infectious Diseases, 1989
• Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects
  New England Journal of Medicine, 1989
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS
  The Lancet, 1983